Enterobiome
Latest round
- Series B
Last raised
- Nov 2021
Total raised
- $14M
Investors
- 7
About Enterobiome
Based in Goyang-si, South Korea, and founded in 2018, Enterobiome Inc. is a microbiome-based new drug development company. Jaegu Seo serves as the CEO of the company as of 2021. The company develops treatments for intractable diseases such as cancer, obesity, diabetes, non-alcoholic liver disease, and atopy based on the species living in the intestinal mucosa of humans. The company has developed its own culture technology and is applying it to prototype production and has created a library of anaerobic strains to be developed as therapeutic agents. The series B investment received in November 2021 will help Enterobiome Inc. in the production of its prototypes and in the development of new microbiome drugs.
Who invested in Enterobiome
7 investors across 3 rounds
See all investors in Enterobiome
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Enterobiome
Who invested in Enterobiome?
Enterobiome has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Enterobiome raised?
Enterobiome has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Enterobiome last raise money?
Enterobiome's most recent round on record is a Series B, in Nov 2021.
What does Enterobiome do?
Based in Goyang-si, South Korea, and founded in 2018, Enterobiome Inc.
Where is Enterobiome headquartered?
Enterobiome is headquartered in Goyang, South Korea.
Which VCs invest in companies like Enterobiome?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Enterobiome's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Enterobiome? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.